‘Emergency Use’ Coronavirus Test With Capacity Ot Deliver Results 45 Mins Allowed By FDA
The rapid molecular test for point-of-care patients developed by Cepheid has been authorized by the United States Food and Drug Administration (FDA) on an emergency basis and now can be used for detecting coronavirus in just 45 minutes This test is the first of its kind that can be used entirely at the point of…








